🌟 What a month of incredible connections! 🌟 We were thrilled to engage with so many industry leaders and innovators this October at some amazing events: 🚀 PBSS International San Francisco – Exciting discussions on AI in biotech! 🌍 BioTechX Europe – Insightful discussions to exploring the future of drug development, it was great to meet so many passionate professionals driving innovation forward. 🤝 Biotech Vendor Services, Inc. – Building meaningful connections and exploring new collaboration opportunities. 🚺 Women In Bio - Engage. Educate. Empower. - Thoughtful discussions and women-to-women mentorship. It was great to meet so many passionate professionals driving innovation forward. We look forward to continuing these conversations and driving innovation forward together! #AIinBiotech #LifeSciences #Networking #PBSS #BiotechX #BVS
Weave
Biotechnology Research
Weave together thousands of pages of source documents and accelerate your IND submission
About us
Weave Bio is an AI-native, life sciences platform company that provides a technically robust, AI-enabled platform for major pain points inherent in the pharma and biotech industries. Our flagship product, AutoIND, is the first offering on Weave’s comprehensive Regulatory Automation and Lifecycle Management (ReALM) platform. With AutoIND we streamline the Investigational New Drug (IND) application process and enable drug development teams to build a living record of their therapeutic candidates, delivering significant improvements in both efficiency and quality. AutoIND automatically generates content based on users’ own source data, regulatory guidelines, and public information. The solution offers a robust, in-platform process for quality review and significantly enhances editing capabilities and oversight for teams. While conventional IND preparation processes can take more than a year, AutoIND can produce a first draft of an IND in a single day and reduce the overall time to generate a final IND submission by over 50%, returning capacity to regulatory teams, lowering costs, and ultimately accelerating the time it takes to get treatments to patients. For more information, visit weave.bio
- Website
-
https://www.weave.bio/
External link for Weave
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Privately Held
- Founded
- 2023
Employees at Weave
-
Ari Caroline
Co-Founder & CEO @ Weave | Accelerating INDs at the speed of AI| First Chief Analytics Officer @ Memorial Sloan Kettering
-
Christine Aylward
-
Tammy L.
Experienced Field Marketing Manager | Driving Engagement and Revenue Through Strategic Campaign and Event Planning
-
✟Wes Galliher, Ph.D.
Outcomes-Obsessed Product Leader in B2B SaaS | Using Customer Data Insights to Help My Teams Build the Right Products, Faster
Updates
-
🚀 𝗦𝘁𝗮𝘆 𝗮𝗵𝗲𝗮𝗱 𝗼𝗳 𝘁𝗵𝗲 𝗴𝗮𝗺𝗲 𝘄𝗶𝘁𝗵 𝗔𝘂𝘁𝗼-𝗨𝗽𝗱𝗮𝘁𝗲! 🚀 Having the most up-to-date data to work with is critical. It allows you to make faster, more informed updates throughout your dossier. 📝🔄 #𝗔𝘂𝘁𝗼𝗜𝗡𝗗 is equipped to automatically refresh content with real-time syncing and seamless integration of new source documents as soon as they are added to the Weave platform. Auto-Update empowers you to: ✅ Keep your team working with the most accurate information ✅ Boost efficiency, allowing you to respond to changes quickly ✅ Save time and eliminate repetitive tasks 📽️ View its capabilities in action 👉 Schedule time with us to learn more: info@weave.bio #WeaveWednesdays #AutoIND #RegOps #HealthAI #INDSubmissions
-
AI—Not So Scary After All! 👻 🦇 Before the moon is full, let’s take a moment to dispel the spooky myths about AI!💀 It’s not lurking in the shadows or casting spells—it's here to help make our lives easier. Think of AI as a friendly Frankenstein 🧟♂️ here to handle the heavy lifting and not to terrorize the town. Whether it’s automatically organizing data, completing instruction based tasks, meeting deadlines faster, or simply saving your sanity, it's the friendliest ghost in the tech world! 👻💻✨ So, this Halloween, let’s give a scream to the not-so-scary tech that’s working behind the scenes to give you more time to enjoy your favorite Halloween treats (hello, 🍬 🌽 ). #SpookySmartTech #NoMoreWorkNightmares #AIOrTreat #Weave #AutoIND
-
-
🌟 𝗔𝗜 𝗶𝘀 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗕𝗶𝗼𝘁𝗲𝗰𝗵—𝗪𝗵𝗮𝘁’𝘀 𝗬𝗼𝘂𝗿 𝗡𝗲𝘅𝘁 𝗠𝗼𝘃𝗲? 🌟 The 2024 BIO Investor Forum highlighted what many in biotech are already seeing firsthand: AI isn’t just hype anymore—it’s transforming the industry by speeding up discovery, enhancing research models, and streamlining clinical trials. Experts from NVIDIA, OmniaBio, and Medable, Inc emphasized that AI helps companies unlock value, reduce timelines, and realize tangible ROI across the value chain. 🚀 At Weave, we’re embracing this revolution with #𝗔𝘂𝘁𝗼𝗜𝗡𝗗. 💡 Imagine the time you could save and the risks you could reduce by integrating AI into your regulatory strategy. Our AI-driven tools aren’t just about innovation—they’re about making real-world impacts on the speed and efficiency of bringing life-changing therapies to market. Ready help your team harness the power of AI to stay ahead in today’s biotech landscape? 👉 Contact us at info@weave.bio. 📖 Read more: https://lnkd.in/eJX55t6u #AIinBiotech #BiotechInnovation #RegulatoryAffairs #AutoIND #AIDriven #ClinicalTrials
-
Weave understands that all IND projects are not created equal. That's why we offer template options that can be adapted to fit the unique needs of your team: ✔️built-in templates ✔️customization options ✔️ability to bring your own into #AutoIND It's just one more way Weave let's you extend your team capabilities without giving up control. 🎥 See how easy it is to use your existing or new templates. 👉 Then schedule time with us to learn more: info@weave.bio #WeaveWednesdays #AutoIND #RegOps #HealthAI #INDSubmissions
-
📢 Exciting News! We're Growing! Weave is thrilled to welcome Tammy Lyons, CMP as our Senior Marketing Manager! 🎉 With her extensive background in marketing strategy, digital campaigns, and brand development, she will be instrumental in driving our next phase of growth and helping us expand our impact in the biotech industry. Join us in giving a warm welcome to Tammy! We can't wait to see all the innovative ideas she will bring to the table. 🙌 #WeaveBio #TeamGrowth #MarketingManager #Biotech #Innovation
-
-
💻 Did you stop scrolling long enough to read this article 👉 Navigating the Regulatory Maze: Top CMC Questions for a Successful IND If you are new to regulatory operations or medical writing just know that understanding #CMC requirements is critical to acing your IND submission. It really is a maze - from process validation to quality control and beyond. Experts who ask the right questions can influence and simplify their path through regulatory complexities. ⚡ Check out this insightful guide on the top CMC questions to elevate your submission process and ensure compliance. https://lnkd.in/gyrYRa9N #BiotechRegulations #CMCCompliance #DrugDevelopment #INDSubmission #PharmaInnovation
Navigating the Regulatory Maze: Top CMC Questions to Ace Your IND Application
Edward Narke on LinkedIn
-
Even with your final study reports in hand, it's a lot of work to review and edit an #INDsubmission. Our AI-native platform, #AutoIND, simplifies this work - offering independent, collaborative, and AI-driven tools to edit, review, and refine your draft IND. Call on support from AI-reviewers. Insert figures and images to enrich information in auto-generated as texts and tables. Re-write content with instructions given to our AI. And do it all with quick access to our version history. 🎥 Get a quick glimpse of the functionality here 👉 Then schedule time with us to learn more: info@weave.bio #WeaveWednesdays #AutoIND #RegOps #HealthAI #INDSubmissions
-
📣 Raleigh-Durham - don't miss this event! 📣 Join us tomorrow for an afternoon of networking, scientific exhibits plus food & drinks at the Alexandria Real Estate Equities, Inc. and Biotech Vendor Services, Inc. Scientific Innovation Expo in RTP. 🤝 Weave's Umut Eser will be on hand to discuss how #AutoIND can streamline regulatory workflows, accelerate timelines, and reduce risks. 👉 Don’t miss out on this opportunity to learn more about the human + AI future of regulatory processes!
-
-
🚀 AI Revolution: Physics Meets Innovation! 🚀 Congrats to the 2024 Physics Nobel Laureates, John J. Hopfield and Geoffrey E. Hinton, for their pivotal role in advancing machine learning and artificial neural networks. Their groundbreaking discoveries have enabled machines to mimic learning and memory—changing the landscape of AI forever. Thanks to innovators like Hopfield and Hinton, Weave is able to push the boundaries of what's possible in biotech.💡🌐 #NobelPrize #AIRevolution #RegulatoryInnovation #Weave #MachineLearning #BiotechTransformation
BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Physics to John J. Hopfield and Geoffrey E. Hinton “for foundational discoveries and inventions that enable machine learning with artificial neural networks.” This year’s two Nobel Prize laureates in physics have used tools from physics to develop methods that are the foundation of today’s powerful machine learning. John Hopfield created an associative memory that can store and reconstruct images and other types of patterns in data. Geoffrey Hinton invented a method that can autonomously find properties in data, and so perform tasks such as identifying specific elements in pictures. When we talk about artificial intelligence, we often mean machine learning using artificial neural networks. This technology was originally inspired by the structure of the brain. In an artificial neural network, the brain’s neurons are represented by nodes that have different values. These nodes influence each other through connections that can be likened to synapses and which can be made stronger or weaker. The network is trained, for example by developing stronger connections between nodes with simultaneously high values. This year’s laureates have conducted important work with artificial neural networks from the 1980s onward. John Hopfield invented a network that uses a method for saving and recreating patterns. We can imagine the nodes as pixels. The Hopfield network utilises physics that describes a material’s characteristics due to its atomic spin – a property that makes each atom a tiny magnet. The network as a whole is described in a manner equivalent to the energy in the spin system found in physics, and is trained by finding values for the connections between the nodes so that the saved images have low energy. When the Hopfield network is fed a distorted or incomplete image, it methodically works through the nodes and updates their values so the network’s energy falls. The network thus works stepwise to find the saved image that is most like the imperfect one it was fed with. Geoffrey Hinton used the Hopfield network as the foundation for a new network that uses a different method: the Boltzmann machine. This can learn to recognise characteristic elements in a given type of data. Hinton used tools from statistical physics, the science of systems built from many similar components. The machine is trained by feeding it examples that are very likely to arise when the machine is run. The Boltzmann machine can be used to classify images or create new examples of the type of pattern on which it was trained. Hinton has built upon this work, helping initiate the current explosive development of machine learning. Learn more Press release: https://bit.ly/4gCTwm9 Popular information: https://bit.ly/3Bnhr9d Advanced information: https://bit.ly/3TKk1MM
-